XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balances at Dec. 31, 2020 $ 1,964 $ 102,651,304 $ (98,234,151) $ 160,642 $ 4,579,759
Balances (in Shares) at Dec. 31, 2020 19,642,401        
Sale of common stock for cash $ 164 10,282,834     10,282,998
Sale of common stock for cash (in Shares) 1,642,856        
Stock-based compensation 4,795,069 4,795,069
Settlement of accrued expense with stock options 349,376 349,376
Cashless stock option exercise $ 40 (40)
Cashless stock option exercise (in Shares) 412,569        
Cashless warrant exercise $ 27 (27)
Cashless warrant exercise (in Shares) 263,661        
Warrant exercise for cash $ 6 273,747 273,753
Warrant exercise for cash (in Shares) 60,834        
Convertible note converted to common stock $ 117 6,232,223 6,232,340
Convertible note converted to common stock (in Shares) 1,171,296        
Stock option exercise for cash $ 1 24,659 24,660
Stock option exercise for cash (in Shares) 4,802        
Net loss (10,746,514) (10,746,514)
Foreign currency translation 60,991 60,991
Balance at Sep. 30, 2021 $ 2,319 124,609,145 (108,980,665) 221,633 15,852,432
Balance (in Shares) at Sep. 30, 2021 23,198,419        
Balances at Jun. 30, 2021 $ 2,137 111,493,973 (103,781,760) 202,667 7,917,017
Balances (in Shares) at Jun. 30, 2021 21,363,027        
Sale of common stock for cash $ 164 10,282,834 10,282,998
Sale of common stock for cash (in Shares) 1,642,856        
Stock-based compensation 2,533,943 2,533,943
Cashless stock option exercise $ 11 (11)
Cashless stock option exercise (in Shares) 125,998        
Cashless warrant exercise
Cashless warrant exercise (in Shares) 902        
Warrant exercise for cash $ 6 273,747 273,753
Warrant exercise for cash (in Shares) 60,834        
Stock option exercise for cash $ 1 24,659 24,660
Stock option exercise for cash (in Shares) 4,802        
Net loss (5,198,905) (5,198,905)
Foreign currency translation 18,966 18,966
Balance at Sep. 30, 2021 $ 2,319 124,609,145 (108,980,665) 221,633 15,852,432
Balance (in Shares) at Sep. 30, 2021 23,198,419        
Balances at Dec. 31, 2021 $ 2,329 126,581,702 (115,899,939) 211,486 10,895,578
Balances (in Shares) at Dec. 31, 2021 23,294,024        
Stock-based compensation 6,726,871 6,726,871
Sale of common stock for cash, net of offering costs $ 106 3,146,834 3,146,940
Sale of common stock for cash, net of offering costs (in Shares) 1,063,514        
Common stock issued with convertible debt $ 3 91,754 91,757
Common stock issued with convertible debt (in Shares) 28,496        
Common stock issued for working capital facility $ 10 302,990 303,000
Common stock issued for working capital facility (in Shares) 100,000        
Shares issued in lieu of interest $ 18 473,794 473,812
Shares issued in lieu of interest (in Shares) 191,714        
Warrants for services with the issuance of convertible debt 449,474 449,474
Cashless stock option exercise $ 19 (19)
Cashless stock option exercise (in Shares) 185,111        
Cashless warrant exercise
Cashless warrant exercise (in Shares) 1,377        
Warrant exercise for cash $ 4 65,999 66,003
Warrant exercise for cash (in Shares) 36,668        
Convertible note converted to common stock $ 1 49,999 $ 50,000
Convertible note converted to common stock (in Shares) 13,514        
Stock option exercise for cash (in Shares)         281,031
Net loss (18,208,504) $ (18,208,504)
Foreign currency translation (72,431) (72,431)
Balance at Sep. 30, 2022 $ 2,490 137,889,398 (134,108,443) 139,055 3,922,500
Balance (in Shares) at Sep. 30, 2022 24,914,418        
Balances at Jun. 30, 2022 $ 2,478 135,322,838 (127,773,494) 176,438 7,728,260
Balances (in Shares) at Jun. 30, 2022 24,789,418        
Stock-based compensation 2,227,764 2,227,764
Shares issued in lieu of interest $ 7 222,798 222,805
Shares issued in lieu of interest (in Shares) 74,818        
Warrant exercise for cash $ 4 65,999 66,003
Warrant exercise for cash (in Shares) 36,668        
Convertible note converted to common stock $ 1 49,999 50,000
Convertible note converted to common stock (in Shares) 13,514        
Net loss (6,334,949) (6,334,949)
Foreign currency translation (37,383) (37,383)
Balance at Sep. 30, 2022 $ 2,490 $ 137,889,398 $ (134,108,443) $ 139,055 $ 3,922,500
Balance (in Shares) at Sep. 30, 2022 24,914,418